NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Spore.Bio

Spore.Bio

Private
ParisFrontier & Industrial Techhttps://spore.bio/

Last Round

Grant

Jan 8, 2026

Total Funding Raised

$31.3M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

Spore.Bio is a biotechnology company that has developed an AI-powered technology for real-time microbiology testing.

Sector

Frontier & Industrial Tech

Verticals

Biotech Equipment, Biotechnology, Quality Management, Smart Manufacturing

Business Model

B2B

Customer Profile

Hardware + Subscription, Subscription SaaS

AI Layer

Application

Keywords

microbiological testingquality controlautomated microbiologyrapid microbial detectionindustrial biotechspectral imagingsmart manufacturingbiotech hardwareAI quality controllab automationhardware-enabled SaaSfood safety testingpharma quality controlmicrobial monitoringlab-on-a-chipat-line testing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Spore.Bio Comparables

Compare Spore.Bio with similar companies based on industry and business-model similarity.

Spore.Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Myriad Optics
84%
Rapid Micro Biosystems
74%
Charles River Laboratories
72%

Spore.Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJan 8, 2026
Series AFeb 19, 2025
Pre SeedDec 12, 2023

Key People

Founding team and executive leadership

Maxime Mistretta

Co-founder CTO

Founding Team

Mohamed Tazi

Co-Founder COO

Founding Team

Amine Raji

Co-Founder CEO

Founding Team

Spore.Bio Investors

Notable investors and investment history

Spore.Bio investors
InvestorRounds
LocalGlobeSeries A, Pre Seed
SingularSeries A
EmergingTech VenturesPre Seed
1st Kind by Peugeot FamilySeries A
Better AnglePre Seed
Phoenix Court GroupSeries A, Pre Seed
No Label VenturesSeries A, Pre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 13, 2026

    Open roles increased to 77, 115% of headcount.

  • Jun 26, 2026

    Grew 16% QoQ, from 58 to 67 employees.

Spore.Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Spore.Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Spore.Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersParis
Employee Range67
Year Founded2023
Last FundingJan 8, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.